selected publications
- Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors. Advances in pharmacology (San Diego, Calif.). 2024 Review GET IT
- Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome. ACS chemical neuroscience. 2024 Academic Article GET IT
- Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer's Disease. ACS omega. 2024 Academic Article GET IT
-
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold.
Journal of medicinal chemistry.
2023
Academic Article
GET IT
Times cited: 6 -
A patent review of NLRP3 inhibitors to treat autoimmune diseases.
Expert opinion on therapeutic patents.
2023
Review
GET IT
Times cited: 10 -
Alzheimer's Disease: Treatment of Multi-Factorial Disorders with Multi- Target Approach.
Mini reviews in medicinal chemistry.
2023
Academic Article
GET IT
Times cited: 2